Ignite Creation Date:
2024-05-06 @ 3:27 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633278
Status:
TERMINATED
Last Update Posted:
2024-02-02
First Post:
2020-10-26
Brief Title:
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-26
First Submit QC Date:
November 11 2020
Study First Post Date:
2020-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-21
Last Update Post Date:
2024-02-02
Last Update Post Date Type:
ACTUAL